STAT in a recent article offers a rundown of the seven pharmaceutical executives slated to testify before Congress on drug pricing.
Below are the representatives who will testify:
- Pascal Soriot, AstraZeneca;
- Kenneth Frazier, Merck;
- Olivier Brandicourt, Sanofi;
- Richard Gonzalez, AbbVie;
- Jennifer Taubert, Johnson & Johnson;
- Albert Bourla, Pfizer; and
- Giovanni Caforio; Bristol-Myers Squibb.